Sanders Morris Harris’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,600
| Closed | -$1.02M | – | 279 |
|
|
2025
Q1 | $1.02M | Hold |
4,600
| – | – | 0.16% | 85 |
|
|
2024
Q4 | $1.05M | Hold |
4,600
| – | – | 0.16% | 97 |
|
|
2024
Q3 | $1.12M | Hold |
4,600
| – | – | 0.19% | 79 |
|
|
2024
Q2 | $881K | Hold |
4,600
| – | – | 0.14% | 98 |
|
|
2024
Q1 | $911K | Hold |
4,600
| – | – | 0.17% | 96 |
|
|
2023
Q4 | $794K | Hold |
4,600
| – | – | 0.39% | 67 |
|
|
2023
Q3 | $670K | Hold |
4,600
| – | – | 0.14% | 115 |
|
|
2023
Q2 | $987K | Buy |
+4,600
| New | +$987K | 0.22% | 63 |
|
|
2023
Q1 | – | Sell |
-4,600
| Closed | -$957K | – | 231 |
|
|
2022
Q4 | $957K | Hold |
4,600
| – | – | 0.36% | 54 |
|
|
2022
Q3 | $1.03M | Hold |
4,600
| – | – | 0.25% | 61 |
|
|
2022
Q2 | $992K | Hold |
4,600
| – | – | 0.22% | 69 |
|
|
2022
Q1 | $1.12M | Hold |
4,600
| – | – | 0.22% | 76 |
|
|
2021
Q4 | $1.19M | Hold |
4,600
| – | – | 0.21% | 79 |
|
|
2021
Q3 | $1.18M | Hold |
4,600
| – | – | 0.21% | 82 |
|
|
2021
Q2 | $1.14M | Hold |
4,600
| – | – | 0.22% | 87 |
|
|
2021
Q1 | $907K | Hold |
4,600
| – | – | 0.19% | 95 |
|
|
2020
Q4 | $996K | Hold |
4,600
| – | – | 0.23% | 80 |
|
|
2020
Q3 | $812K | Buy |
+4,600
| New | +$812K | 0.22% | 94 |
|
|
2020
Q2 | – | Sell |
-18,758
| Closed | -$2.93M | – | 192 |
|
|
2020
Q1 | $2.93M | Buy |
18,758
+758
| +4% | +$118K | 2.86% | 8 |
|
|
2019
Q4 | $2.81M | Hold |
18,000
| – | – | 0.64% | 34 |
|
|
2019
Q3 | $2.32M | Hold |
18,000
| – | – | 0.56% | 40 |
|
|
2019
Q2 | $2.21M | Buy |
+18,000
| New | +$2.21M | 0.57% | 40 |
|